Home » Business News » 2011 » November » November 24, 2011

Signature Diagnostics to Present at the 23rd Annual Piper Jaffray Health Care Conference

November 24, 2011 - Potsdam, Germany

Signature Diagnostics /Signature Diagnostics to Present at the 23rd Annual Piper Jaffray Health CareConference. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Potsdam, Germany, November 24, 2011 - Signature Diagnostics AG announced todaythat André Rosenthal, Chief Executive Officer of Signature Diagnostics, willpresent at the 23(rd) Annual Piper Jaffray Health Care Conference on Wednesday,November 29(th) at 11:10 a.m. Eastern Time at the New York Palace Hotel in NewYork City. Dr. Rosenthal will provide an overview of the company and itsdevelopment and commercial programs including its blood-based Detector C testsuite for early detection of Colorectal cancer.

About Signature Diagnostics AG
Signature Diagnostics AG is a molecular diagnostics company based in Potsdam,Germany, focusing on the development and commercialization of novel molecularoncology diagnostic products for early detection (screening) and prognosis ofcancer. The company has completed development of its first two diagnosticproducts for Colorectal cancer screening ("Detector C") and prognosis("Predictor C"), which will be launched in 2012 in its own ISO 15189 certifiedservice laboratory. Using its state-of-the-art technologies in tissue and bloodsample collection, molecular pathology, Xenopatient™ platform, genome-wideprofiling, data mining, and biostatistics, the company collaborates withclinical, pharmaceutical, and diagnostic partners. Signature Diagnosticssponsors and conducts large prospective, multicenter clinical trials with morethan 33 primary care hospitals and several dozen colonoscopy centers in Germanyto discover and validate biomarkers in oncology.

--- End of Message ---

Signature Diagnostics
Hermannswerder 20 A Potsdam Germany

Press release (PDF):

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:(i) the releases contained herein are protected by copyright and other applicable laws; and(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Signature Diagnostics via Thomson Reuters ONE


For more information, please contact:
Rainer Kramer, CBO
Signature Diagnostics
Hermannswerder 20A
14473 Potsdam, Germany
phone: +49-331-2000-200


Comment on this story